The US Food and Drug Administration underscores its concerns about kratom’s use as a dietary ingredient by offering $2m for a study on the human abuse potential for the botanical harvested from plants indigenous to Southeast Asia.
The agency’s request published on 17 January runs counter to the kratom industry’s contention that kratom-containing supplements, food and beverages are effective in helping users stop abuse of opioids
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?